CRVS — CORVUS PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 179 家机构在其最新 13F 申报中持有 CRVS(CORVUS PHARMACEUTICALS INC),合计申报市值 $1.07B,对应 75.44M 股。按股数计算较上季度增持 9.3%(+6.05M 股),申报市值环比上升 10.7%。持仓集中度较高:前五大持有人占申报市值的 34.4%,前十大的集中度为 53.2%。
与上一季度相比,42 家新建仓位、70 家加仓、40 家减仓、29 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
CORVUS PHARMACEUTICALS INC(CRVS)的主要机构持有人包括 ORBIMED ADVISORS LLC、BlackRock Inc、PRICE T ROWE ASSOCIATES INC /MD/,按 13F 申报市值在本页 284 家持有人中排名居前。
CRVS 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 120 | 29.71M | $342.45M | -1.3% |
| Q2 2026 | 179 | 75.44M | $1.07B | +9.3% |
| Q1 2026 | 166 | 75.70M | $1.06B | +36.7% |
| Q4 2025 | 130 | 47.51M | $365.53M | -3.4% |
| Q3 2025 | 110 | 42.99M | $316.47M | +4.7% |
| Q2 2025 | 97 | 41.59M | $166.24M | +29.1% |
| Q1 2025 | 93 | 35.31M | $112.29M | -6.8% |
| Q4 2024 | 92 | 38.51M | $206.05M | +6.2% |
表内 8 个季度中,机构持股合计减少 23%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2026(+36.7%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.10M | $81.80M | 0.00% | 减持 | |
| 3.33M | $38.38M | 0.00% | 减持 | |
| 3.32M | $38.24M | 0.00% | 增持 | |
| 2.81M | $32.32M | 3.67% | 持有 | |
| 1.80M | $20.72M | 0.00% | 减持 | |
| 1.04M | $11.99M | 0.00% | 新进 | |
| 792.71K | $9.13M | 0.00% | 减持 | |
| 787.56K | $9.07M | 0.00% | 减持 | |
| 680.02K | $7.83M | 0.22% | 减持 | |
| 641.50K | $7.39M | 2.18% | 增持 | |
| 531.34K | $6.12M | 0.25% | 增持 | |
| 519.26K | $5.98M | 0.00% | 持有 | |
| 423.26K | $4.88M | 0.01% | 增持 | |
| 423.19K | $4.88M | 0.00% | 增持 | |
| 358.60K | $4.13M | 0.78% | 减持 | |
| 351.86K | $4.05M | 0.04% | 增持 | |
| 264.31K | $3.04M | 1.61% | 增持 | |
| 263.66K | $3.04M | 0.29% | 持有 | |
| 231.59K | $2.67M | 0.42% | 持有 | |
| 226.84K | $2.61M | 0.01% | 持有 | |
| 196.47K | $2.26M | 0.00% | 减持 | |
| 188.24K | $2.17M | 0.00% | 减持 | |
| 181.51K | $2.09M | 0.00% | 增持 | |
| 172.12K | $1.98M | 0.06% | 增持 | |
| 154.26K | $1.78M | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.17M | $104.82M | 2.17% | 持有 | |
| 6.16M | $90.13M | 0.00% | 增持 | |
| 3.57M | $52.17M | 0.00% | 增持 | |
| 3.28M | $47.92M | 18.41% | 持有 | |
| 3.23M | $47.32M | 0.00% | 新进 | |
| 2.92M | $42.68M | 0.01% | 增持 | |
| 2.81M | $41.05M | 3.41% | 增持 | |
| 2.50M | $36.56M | 0.00% | 减持 | |
| 2.49M | $36.45M | 0.59% | 新进 | |
| 2.32M | $33.92M | 0.01% | 增持 | |
| 2.32M | $33.92M | 0.01% | 增持 | |
| 2.29M | $33.54M | 0.70% | 增持 | |
| 2.26M | $33.05M | 1.91% | 新进 | |
| 1.83M | $26.79M | 5.82% | 增持 | |
| 1.75M | $25.64M | 0.97% | 新进 | |
| 1.71M | $25.06M | 0.00% | 增持 | |
| 1.67M | $24.50M | 1.89% | 减持 | |
| 1.54M | $22.54M | 0.01% | 增持 | |
| 1.34M | $19.53M | 0.20% | 新进 | |
| 1.10M | $16.09M | 2.11% | 新进 | |
| 1.07M | $15.66M | 0.07% | 新进 | |
| 891.93K | $13.05M | 2.73% | 新进 | |
| 866.36K | $12.67M | 0.01% | 增持 | |
| 866.36K | $12.67M | 0.02% | 增持 | |
| 750.00K | $10.97M | 0.02% | 新进 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.17M | $55.17M | 1.17% | 持有 | |
| 5.06M | $38.93M | 0.00% | 增持 | |
| 3.87M | $29.83M | 0.00% | 增持 | |
| 3.57M | $27.47M | 0.00% | 增持 | |
| 3.28M | $25.22M | 9.56% | 持有 | |
| 2.88M | $22.14M | 0.09% | 减持 | |
| 2.79M | $21.47M | 0.00% | 增持 | |
| 2.74M | $21.13M | 2.42% | 新进 | |
| 2.23M | $17.21M | 1.11% | 持有 | |
| 1.47M | $11.35M | 0.00% | 增持 | |
| 1.38M | $10.64M | 3.21% | 减持 | |
| 729.00K | $5.61M | 2.05% | 减持 | |
| 692.44K | $5.33M | 0.10% | 减持 | |
| 688.77K | $5.30M | 0.00% | 新进 | |
| 688.77K | $5.30M | 0.01% | 新进 | |
| 553.33K | $4.26M | 0.00% | 增持 | |
| 500.00K | $3.85M | 0.28% | 新进 | |
| 465.88K | $3.59M | 0.28% | 新进 | |
| 447.61K | $3.45M | 0.04% | 减持 | |
| 429.77K | $3.31M | 0.00% | 减持 | |
| 407.71K | $3.14M | 0.62% | 持有 | |
| 394.77K | $3.04M | 0.00% | 增持 | |
| 314.68K | $2.42M | 0.00% | 增持 | |
| 314.68K | $2.42M | 0.00% | 增持 | |
| 236.50K | $1.82M | 0.00% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.17M | $52.81M | 1.36% | 持有 | |
| 6.45M | $47.57M | 0.19% | 减持 | |
| 4.71M | $34.72M | 0.00% | 增持 | |
| 3.47M | $25.59M | 0.00% | 增持 | |
| 3.28M | $24.14M | 15.76% | 持有 | |
| 2.68M | $19.75M | 0.24% | 持有 | |
| 2.23M | $16.47M | 1.32% | 持有 | |
| 1.73M | $12.76M | 4.93% | 持有 | |
| 1.46M | $10.74M | 0.00% | 增持 | |
| 1.44M | $10.60M | 0.32% | 持有 | |
| 1.01M | $7.42M | 0.00% | 增持 | |
| 768.50K | $5.66M | 2.44% | 增持 | |
| 617.22K | $4.55M | 0.00% | 减持 | |
| 466.49K | $3.44M | 0.00% | 增持 | |
| 445.67K | $3.28M | 0.00% | 增持 | |
| 407.71K | $3.00M | 0.70% | 增持 | |
| 401.41K | $2.96M | 0.25% | 增持 | |
| 309.15K | $2.28M | 0.00% | 减持 | |
| 203.36K | $1.50M | 0.00% | 减持 | |
| 180.18K | $1.33M | 0.00% | 增持 | |
| 180.18K | $1.33M | 0.00% | 增持 | |
| 177.79K | $1.31M | 0.00% | 增持 | |
| 177.79K | $1.31M | 0.00% | 增持 | |
| 170.00K | $1.25M | 0.91% | 持有 | |
| 169.20K | $1.25M | 0.03% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.17M | $28.66M | 0.75% | 增持 | |
| 7.04M | $28.17M | 0.14% | 增持 | |
| 4.24M | $16.95M | 0.00% | 增持 | |
| 3.28M | $13.12M | 0.00% | 增持 | |
| 3.28M | $13.10M | 9.23% | 持有 | |
| 2.68M | $10.72M | 0.15% | 持有 | |
| 2.23M | $8.94M | 0.92% | 持有 | |
| 1.73M | $6.92M | 3.89% | 增持 | |
| 1.44M | $5.75M | 0.21% | 新进 | |
| 1.36M | $5.45M | 0.00% | 增持 | |
| 894.40K | $3.58M | 0.00% | 增持 | |
| 664.77K | $2.66M | 0.00% | 增持 | |
| 403.15K | $1.61M | 0.00% | 增持 | |
| 343.53K | $1.37M | 0.00% | 增持 | |
| 318.73K | $1.27M | 0.09% | 新进 | |
| 223.91K | $895.65K | 0.00% | 减持 | |
| 212.70K | $850.80K | 0.00% | 减持 | |
| 201.65K | $806.60K | 0.00% | 增持 | |
| 183.09K | $732.38K | 0.18% | 减持 | |
| 170.21K | $680.84K | 0.00% | 减持 | |
| 170.00K | $680.00K | 0.48% | 增持 | |
| 168.00K | $672.00K | 0.02% | 新进 | |
| 165.19K | $660.75K | 0.00% | 减持 | |
| 161.82K | $647.28K | 0.00% | 增持 | |
| 161.82K | $647.28K | 0.00% | 增持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.85M 股 · $27.70M
- Eversept Partners, LP 747.99K 股 · $11.18M
- Trexquant Investment LP 296.35K 股 · $4.43M
- Sixth Street Partners Management Company, L.P. 208.12K 股 · $3.11M
- D. E. Shaw & Co 133.18K 股 · $1.99M
- D. E. Shaw & Co., Inc. 133.18K 股 · $1.99M
- Swiss National Bank 126.50K 股 · $1.89M
- VANGUARD ASSET MANAGEMENT, Ltd 44.22K 股 · $660.63K
- Y-Intercept (Hong Kong) Ltd 43.77K 股 · $653.91K
- Zurcher Kantonalbank (Zurich Cantonalbank) 37.43K 股 · $559.16K
- Engineers Gate Manager LP 36.02K 股 · $538.12K
- Jupiter Topco LLC 28.10K 股 · $419.95K
完全清仓(较上季)
- STATE STREET CORP 卖出 3.57M 股 · $52.17M
- Commodore Capital LP 卖出 2.26M 股 · $33.05M
- MPM BioImpact LLC 卖出 1.67M 股 · $24.50M
- Polar Capital Holdings Plc 卖出 1.07M 股 · $15.66M
- EVENTIDE ASSET MANAGEMENT, LLC 卖出 550.00K 股 · $8.05M
- Logos Global Management LP 卖出 450.00K 股 · $6.58M
- VOLORIDGE INVESTMENT MANAGEMENT, LLC 卖出 278.01K 股 · $4.07M
- Informed Momentum Co LLC 卖出 138.15K 股 · $2.02M
- Renaissance Technologies 卖出 81.31K 股 · $1.19M
- XTX Topco Ltd 卖出 34.30K 股 · $501.88K
- Qube Research & Technologies Ltd 卖出 33.23K 股 · $486.13K
- Composition Wealth, LLC 卖出 30.00K 股 · $438.90K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 7.10M | 7.14M | 6.16M | 5.06M | 4.71M | 4.24M | 1.06M | 1.07M | 603.88K | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 3.33M | — | 3.57M | 2.79M | 1.01M | 664.77K | 230.04K | 205.54K | 178.25K | 120.30K | 120.30K | 138.40K | 138.40K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.32M | 3.29M | 3.23M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 2.81M | 2.81M | 2.81M | 2.23M | 2.23M | 2.23M | 2.23M | 2.23M | 1.50M | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.80M | 1.85M | 1.71M | 1.47M | 1.46M | 1.36M | 590.29K | 566.86K | 563.01K | 460.14K | 371.76K | 360.38K | 360.38K | 342.08K | 297.80K | 297.80K | 298.46K | 298.46K | 298.46K | 284.87K |
| Fisher Asset Management, LLC | 1.04M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 792.71K | 1.34M | 2.50M | 3.57M | 617.22K | 894.40K | 673.52K | 397.36K | 393.26K | 371.40K | 275.36K | 259.65K | 192.51K | 139.63K | 100.16K | 72.61K | 39.32K | 49.35K | 40.86K | 36.88K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 787.56K | 814.75K | 669.89K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EMERALD ADVISERS, LLC | 680.02K | 685.68K | 686.22K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DCF Advisers, LLC | 641.50K | 637.50K | 637.50K | 729.00K | 768.50K | 2.50K | 5.00K | 28.68K | — | — | — | — | — | — | — | — | — | — | — | — |
| EMERALD MUTUAL FUND ADVISERS TRUST | 531.34K | 526.39K | 459.25K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 519.26K | 520.53K | 504.63K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Connor, Clark & Lunn Investment Management Ltd. | 423.26K | 217.75K | 83.91K | 28.12K | — | — | — | — | 137.03K | 83.22K | 88.01K | 71.21K | 70.88K | — | — | — | — | — | — | — |
| UBS Group AG | 423.19K | 396.12K | 289.11K | 212.01K | 162.07K | 89.71K | 36.39K | 52.11K | 15.68K | 13.00K | 4.68K | 6.70K | 6.70K | 6.70K | 11.01K | 4.70K | 22.66K | 22.57K | 14.11K | 9.27K |
| Blue Owl Capital Holdings LP | 358.60K | 608.60K | 545.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Jump Financial, LLC | 351.86K | 313.40K | 147.85K | — | — | — | 45.01K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Propel Bio Management, LLC | 264.31K | 70.38K | 85.79K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Polymer Capital Management (HK) LTD | 263.66K | 263.66K | 183.19K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Spruce Street Capital LP | 231.59K | 231.59K | 231.59K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SEB Asset Management AB | 226.84K | 226.84K | 226.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold CRVS?
As of 2026-Q2, 179 institutional funds reported holding CRVS (CORVUS PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $1.07B.
How many shares of CRVS do institutions own?
13F filers reported 75.44M shares of CRVS, worth $1.07B in aggregate at the end of 2026-Q2.
Is institutional ownership of CRVS rising or falling?
Share counts moved +9.3% versus the prior quarter — accumulation.
Who are the top institutional holders of CRVS?
The largest 13F holders are ORBIMED ADVISORS LLC, BlackRock Inc, PRICE T ROWE ASSOCIATES INC /MD/, ADAMS STREET PARTNERS LLC, Wellington Management Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of CORVUS PHARMACEUTICALS INC?
The major shareholders of CORVUS PHARMACEUTICALS INC (CRVS) by reported 13F value are ORBIMED ADVISORS LLC, BlackRock Inc, PRICE T ROWE ASSOCIATES INC /MD/, ADAMS STREET PARTNERS LLC, Wellington Management Group, among 284 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.